News | September 30, 2008

GE, Gamma Medica-Ideas Extend Pre-Clinical PET, SPECT Deal

October 1, 2008 — GE Healthcare and Gamma Medica-Ideas (GM-I) have extended their product distribution relationship to include joint development of pre-clinical imaging systems.

Under the new agreement, which takes effect today. GM-I will manufacture all pre-clinical PET, SPECT and CT products sold by GE Healthcare, including the new eXplore CT120 and SpeCZT model lines. The companies will jointly pursue new pre-clinical product developments expected to lead to exciting new products for pre-clinical imaging. GE Healthcare will continue promotion, marketing, sales, and service responsibilities.

“GM-I has a long track record of innovation in imaging technologies and the pre-clinical business including the introduction of the first APD based PET scanner and the Triumph tri-modality system,” said Jim Mitchell, general manager of the pre-clinical business for GE Healthcare. “This agreement is tremendously beneficial to both companies, bringing GM-I’s engineering and manufacturing expertise and GE’s sales, marketing and services acumen together as well as combining cutting edge pre-clinical imaging technologies of GE and GMI.”

“This is a great opportunity to harmonize GM-I and GE Healthcare’s unique and innovative CZT SPECT, APD PET and high throughput CT imaging systems,” said Bradley Patt Ph.D., CEO of GM-I.

For more information: www.gehealthcare.com and www.gm-ideas.com

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init